The relevance of SLC22A2 goes beyond CAD, since it is a shared susceptibility locus for T2DM, with common etiological pathways between them (Zhao et al., 2017; Xue et al., 2018; Ray and Chatterjee, 2020). Here, SLC22A2 is linked to coronary artery disorder.